Document Type: RESEARCH PAPER

Authors

• Mihir Sheth ¹
• Daniel Sholder ²
• Joseph Abboud ²
• Mark Lazarus ²
• Gerald Williams Jr ²
• Surena Namdari ²

¹ Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA

² Rothman Institute, Thomas Jefferson University, Department of Orthopaedic Surgery, Philadelphia, PA, USA

Abstract

Background: The projected increase in revision shoulder arthroplasty has increased interest in the outcomes of these
procedures. Glenoid component removal and conversion to a hemiarthroplasty (HA) is an option for aseptic glenoid
loosening after anatomic total shoulder arthroplasty (aTSA).
Methods: We identified patients who had undergone revision shoulder arthroplasty over a 15-year period. 17 patients
met inclusion and exclusion criteria, and a retrospective chart review was conducted for pre-surgical and operative
data. We contacted patients at a mean follow-up of 70 months from revision surgery for implant survival, reoperations
and functional outcomes scores.
Results: Implant survival was estimated to be 88% at 2 years and 67% at 5 years. Mean ASES score for surviving
implants was 58 ± 22. Mean SANE score was 54 ± 24, and mean VAS pain score was 3.5 ± 2.8. Mean SF-12 Mental
and Physical scores were 46 ± 15 and 38 ± 10, respectively. Five patients (50% of those with surviving implants)
reported being either very satisfied or satisfied with the status of their shoulder. There were complications in 6 patients
(35%) and 5 patients (29%) required reoperation.
Conclusion: HA following failed aTSA due to glenoid loosening produced modest clinical results and satisfaction rates.
Reverse arthroplasty may be a more reliable treatment strategy in this patient population.
Level of evidence: IV

Keywords

• Aseptic glenoid loosening
• Hemiarthroplasty
• Implant survival
• Revision arthroplasty
• Shoulder replacement
• Total shoulder arthroplasty

Main Subjects

• Shoulder